Florence Brocard-Granel

Nancy, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

A necrotic purpura

A necrotic purpura

Journal: La Revue de medecine interne

Published: January 17, 2026

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Successful Radiotherapy in Management of Inoperable Trichoblastic Carcinoma: A Case Report.

Successful Radiotherapy in Management of Inoperable Trichoblastic Carcinoma: A Case Report.

Journal: The American journal of case reports

Published: February 26, 2025

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2025

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.

Journal: Melanoma research

Published: November 11, 2024

Central nervous system complications of immune checkpoint inhibitors: A comprehensive review.

Central nervous system complications of immune checkpoint inhibitors: A comprehensive review.

Journal: Critical reviews in oncology/hematology

Published: September 13, 2024

Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment.

Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment.

Journal: Immunotherapy

Published: September 13, 2024

Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.

Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.

Journal: Cancer

Published: August 08, 2024

The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

Journal: The British journal of dermatology

Published: July 17, 2024

A strange blue leg

A strange blue leg

Journal: La Revue de medecine interne

Published: May 15, 2024

Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM.

Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 14, 2024

When to stop immunotherapy for advanced melanoma: the emulated target trials.

When to stop immunotherapy for advanced melanoma: the emulated target trials.

Journal: EClinicalMedicine

Published: January 31, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026